DB00123
 OpenBabel03181420362D

 10  9  0  0  1  0  0  0  0  0999 V2000
    4.9509    1.1592    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365    2.3967    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075    1.5717    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930   -2.1409    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.0784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    0.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8075   -0.9034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220    1.1592    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.0930   -1.3159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2365    1.5717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0  0  0  0
  2 10  2  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8  3  1  6  0  0  0
  8 10  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB00123

> <DRUG_GROUPS>
approved; nutraceutical

> <GENERIC_NAME>
L-Lysine

> <SYNONYMS>
(S)-2,6-diaminohexanoic acid; (S)-lysine; (S)-α,ε-diaminocaproic acid; L-lys; LYS; lysine acid

> <BRANDS>
Enisyl

> <CHEMICAL_FORMULA>
C6H14N2O2

> <MOLECULAR_WEIGHT>
146.1876

> <EXACT_MASS>
146.105527702

> <IUPAC_NAME>
(2S)-2,6-diaminohexanoic acid

> <INCHI_IDENTIFIER>
InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1

> <INCHI_KEY>
InChIKey=KDXKERNSBIXSRK-YFKPBYRVSA-N

> <SMILES>
NCCCC[C@H](N)C(O)=O

> <JCHEM_ACCEPTOR_COUNT>
4

> <JCHEM_DONOR_COUNT>
3

> <JCHEM_ACIDIC_PKA>
2.74

> <JCHEM_BASIC_PKA>
10.29

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <ALOGPS_LOGP>
-3.8

> <JCHEM_LOGP>
-3.2

> <ALOGPS_LOGS>
-0.14

> <JCHEM_POLARIZABILITY>
15.84

> <JCHEM_POLAR_SURFACE_AREA>
89.34

> <JCHEM_REFRACTIVITY>
37.81

> <JCHEM_ROTATABLE_BOND_COUNT>
5

> <ALOGPS_SOLUBILITY>
1.05e+02 g/l __ __ 

$$$$
